|

Ropivacaine 0.2% Injectable Solution Clinical Trials

5 actively recruiting trials

▲ +1 trial since June 2026

Also known as: 0.2% ropivacaine, Ropivacaine hydrochloride

Pipeline

Phase 4: 1

Top Sponsors

  • Poznan University of Medical Sciences5

Indications

  • Arthritis5
  • Hip Osteoarthritis4
  • Arthropathy of Hip1
  • Hip Pain Chronic1
  • Hip Arthropathy1

Other5 trials

Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA
N/A
PENG Block With Dexmedetomidine in Older Adults
N/A
PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
Phase 4
SII Levels Following PENG Block in Hip Arthroplasty
N/A
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.